[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Direct-Fed Microbials Market by Type (Lactic Acid Bacteria and Bacillus), Livestock (Pork/Swine, Poultry, Ruminant, and Aquatic Animals), Form (Dry and Liquid), and Region - Global Forecast to 2022

January 2017 | 154 pages | ID: D8100D3A646EN
MarketsandMarkets

US$ 3,955.00 US$ 5,650.00 -30 %
Offer valid until March 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
“Global direct-fed microbials market projected to have a CAGR of 6.96%.”

The global direct-fed microbials market is projected to reach a value of USD 1,399.6 million by 2022, growing at a CAGR of 6.96% from 2016. The demand for direct-fed microbials in animal feed is projected to grow during the forecast period owing to the rapidly increasing global demand for quality animal products. The market is influenced by the growing awareness among consumers about preventive healthcare and nutrition. Factors such as low shelf life and high cost of direct-fed microbials are leading to a rise in the cost of production and restraining the growth of the market.

“Lactic acid bacteria segment accounted for the largest market share among the types of direct-fed microbials in 2015.”

On the basis of type, direct-fed microbials have been segmented into lactic acid bacteria, bacillus, and others which include prevotella bryantii, live beneficial bacteria, and Propionibacterium. Among these, the lactic acid bacteria segment accounted for the largest share in 2015, followed by the bacillus segment. Lactic acid bacteria are widely used for feed of poultry and ruminants, for healthy growth.

“Poultry segment led the market with the largest share in 2015.”

On the basis of livestock, the direct-fed microbials market has been segmented into swine, ruminants, poultry, aquatic animals, and others which include equine and pets. The market was led by the poultry segment, followed by ruminants. The role of direct-fed microbials in poultry includes altering the metabolism by enhancing digestive enzyme activity, maintaining normal intestinal microflora, and reducing bacterial enzyme activity and ammonia production.

“North America dominated the market with the largest share in 2015.”

North America formed the largest market for direct-fed microbials in 2015, whereas Europe accounted for the second-largest market share in 2015. The application of direct-fed microbials in animal feed is expected to increase at a faster pace in Europe and the Asia-Pacific region due to the rising demand. The farming techniques used in the region require healthy and strong farm animals; direct-fed microbials help in balancing the digestive systems and enhancing the immunity systems of livestock.

Livestock has always been an important industry in the North American agriculture sector and shows a positive future outlook, due to increasing meat exports as well as rising consumption within the country. Canada has the advantage of lower feed cost due to the small biofuel industry, which allows more grain input in livestock breeding.

Breakdown of profiles of primary participants is as follows:
  • By Company Type: Tier 1 – 30 %, Tier 2 – 45%, and Tier 3 – 25%
  • By Designation: Directors – 22%, C level – 28%, and Manager level – 50%
  • By Region: North America – 35%, Europe – 23%, Asia-Pacific – 32%, and RoW – 10%
The key players identified in the global direct-fed microbials market include Archer Daniels Midland Company (U.S.), E. I. du Pont de Nemours and Company (U.S.), Koninklijke DSM N. V. (Netherlands), Novozymes (Denmark), Chr. Hansen A/S (Denmark), Kemin Industries (U.S.), BIOMIN Holding GmbH (Austria), Lallemand Inc. (Canada), Novus International, Inc. (U.S.), and Bio-vet (U.S.).

Research Coverage:
  • This study estimates the global market size of direct-fed microbials, in terms of dollar value, till 2022, segmented on the basis of type, livestock, and form.
  • It offers a detailed qualitative and quantitative analysis of this market with reference to the competitive landscape and preferred development strategies such as expansions and investments, and to gain a larger share in the market.
  • It provides a comprehensive review of major market drivers, restraints, opportunities, challenges, and key issues of the market
Reasons to buy this report:

From an insight perspective, this research report has focused on various levels of analyses—market sizing, industry analysis (industry trends), market share analysis of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape as well as dynamics of the study market.

The report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on direct-fed microbials offered by the top players in the global market
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the market
  • Market Development: Comprehensive information about lucrative emerging markets across various regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global market
  • Competitive Assessment: In-depth assessment of market share, strategies, products, and manufacturing capabilities of the leading players in the global market
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
  1.3.1 MARKET COVERED
  1.3.2 PERIODIZATION
1.4 CURRENCY
1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 INTRODUCTION
2.2 RESEARCH DATA
  2.2.1 SECONDARY DATA
    2.2.1.1 Key data from secondary sources
  2.2.2 PRIMARY DATA
    2.2.2.1 Key data from primary sources
    2.2.2.2 Key industry insights
    2.2.2.3 Breakdown of primary interviews
2.3 MARKET SIZE ESTIMATION
  2.3.1 BOTTOM-UP APPROACH
  2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS & LIMITATIONS
  2.5.1 ASSUMPTIONS
  2.5.2 LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 ATTRACTIVE OPPORTUNITIES IN THE DIRECT-FED MICROBIALS MARKET
4.2 DIRECT-FED MICROBIALS MARKET, BY LIVESTOCK
4.3 LIFE CYCLE ANALYSIS: DIRECT-FED MICROBIALS MARKET, BY REGION
4.4 DIRECT-FED MICROBIALS MARKET, BY TYPE
4.5 DIRECT-FED MICROBIALS MARKET, BY KEY COUNTRY
4.6 DIRECT-FED MICROBIALS MARKET, BY FORM & REGION

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MACROINDICATORS
  5.2.1 INCREASE IN MEAT PRODUCTION/CONSUMPTION
  5.2.2 GROWING LIVESTOCK POPULATION
  5.2.3 PARENT MARKET ANALYSIS: ANIMAL FEED INDUSTRY
5.3 MARKET SEGMENTATION
  5.3.1 BY TYPE
  5.3.2 BY FORM
  5.3.3 BY LIVESTOCK
  5.3.4 BY REGION
5.4 MARKET DYNAMICS
  5.4.1 DRIVERS
    5.4.1.1 Increasing awareness about animal health
    5.4.1.2 Rise in global meat and milk consumption
    5.4.1.3 Increased demand for quality animal products
    5.4.1.4 Increase in demand for animal protein
  5.4.2 RESTRAINTS
    5.4.2.1 Varying regulations pertaining to consumption of bacteria in food and feed
  5.4.3 OPPORTUNITIES
    5.4.3.1 Ban on the usage of antibiotic growth promoters (AGP)
    5.4.3.2 Health benefits for livestock in the wake of rising animal health concerns
  5.4.4 CHALLENGES
    5.4.4.1 Increasing cost of production and operations
5.5 PARENT MARKET ANALYSIS

6 INDUSTRY TRENDS

6.1 INTRODUCTION
6.2 GLOBAL DIRECT-FED MICROBIALS IN ANIMAL FEED MARKET: SUPPLY CHAIN ANALYSIS
  6.2.1 INDUSTRY INSIGHTS
6.3 DIRECT-FED MICROBIALS IN ANIMAL FEED MARKET: PORTER’S FIVE FORCES ANALYSIS
  6.3.1 INTENSITY OF COMPETITIVE RIVALRY
  6.3.2 BARGAINING POWER OF SUPPLIERS
  6.3.3 BARGAINING POWER OF BUYERS
  6.3.4 THREAT OF SUBSTITUTES
  6.3.5 THREAT OF NEW ENTRANTS

7 DIRECT-FED MICROBIALS MARKET, BY TYPE

7.1 INTRODUCTION
7.2 LACTIC ACID BACTERIA
  7.2.1 LACTOBACILLI
    7.2.1.1 Research on Lactobacilli
  7.2.2 BIFIDOBACTERIA
    7.2.2.1 Research on Bifidobacteria
  7.2.3 STREPTOCOCCUS THERMOPHILUS
7.3 BACILLUS SUBTILIS
  7.3.1 BACILLUS LICHENIFORMIS
7.4 OTHER BACTERIA

8 DIRECT-FED MICROBIALS MARKET, BY LIVESTOCK

8.1 INTRODUCTION
8.2 SWINE
8.3 POULTRY
8.4 RUMINANTS
8.5 AQUATIC ANIMALS
8.6 OTHERS

9 DIRECT-FED MICROBIALS MARKET, BY FORM

9.1 INTRODUCTION
9.2 DRY FORM
9.3 LIQUID FORM

10 DIRECT-FED MICROBIALS MARKET, BY REGION

10.1 INTRODUCTION
10.2 NORTH AMERICA
  10.2.1 U.S.
  10.2.2 CANADA
  10.2.3 MEXICO
10.3 EUROPE
  10.3.1 U.K.
  10.3.2 GERMANY
  10.3.3 FRANCE
  10.3.4 ITALY
  10.3.5 SPAIN
  10.3.6 REST OF EUROPE
10.4 ASIA-PACIFIC
  10.4.1 CHINA
  10.4.2 INDIA
  10.4.3 JAPAN
  10.4.4 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD (ROW)
  10.5.1 LATIN AMERICA
  10.5.2 MIDDLE EAST AND AFRICA

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW
11.2 DIRECT-FED MICROBIALS MARKET: COMPANY RANKING
11.3 COMPETITIVE SITUATION & TRENDS
11.4 EXPANSIONS & INVESTMENTS: THE KEY STRATEGY, 2011–2016
  11.4.1 EXPANSIONS & INVESTMENTS
  11.4.2 MERGERS & ACQUISITIONS
  11.4.3 NEW PRODUCT LAUNCHES
  11.4.4 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES

12 COMPANY PROFILES

(Company at a Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*

12.1 ARCHER DANIELS MIDLAND COMPANY
12.2 E.I. DUPONT DE NEMOURS AND COMPANY
12.3 KONINKLIJKE DSM N.V.
12.4 NOVOZYMES
12.5 CHR. HANSEN HOLDING A/S
12.6 KEMIN INDUSTRIES, INC.
12.7 BIOMIN HOLDING GMBH
12.8 LALLEMAND, INC.
12.9 NOVUS INTERNATIONAL, INC.
12.10 BIO-VET

*Details on company at a glance, recent financials, products & services, strategies & insights, & recent developments might not be captured in case of unlisted companies.

13 APPENDIX

13.1 DISCUSSION GUIDE
  13.1.1 EXPANSIONS & INVESTMENTS
  13.1.2 MERGERS & ACQUISITIONS
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS

LIST OF TABLES

Table 1 PER CAPITA CONSUMPTION OF MEAT THROUGH 2030
Table 2 PER CAPITA PROTEIN SUPPLY FOR KEY COUNTRIES, 2006-2009 (GRAMS/DAY)
Table 3 EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 4 EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 5 EUBIOTICS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION)
Table 6 INDUSTRY INSIGHTS: LEADING TRENDS AMONG KEY PLAYERS
Table 7 DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
Table 8 LACTIC ACID BACTERIA MARKET SIZE, BY REGION, 2014-2022 (USD MILLION)
Table 9 BACILLUS SUBTILIS MARKET SIZE, BY REGION, 2014-2022 (USD MILLION)
Table 10 OTHER BACTERIA MARKET SIZE, BY REGION, 2014-2022 (USD MILLION)
Table 11 DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 12 SWINE: DIRECT-FED MICROBIALS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION)
Table 13 POULTRY: DIRECT-FED MICROBIALS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION)
Table 14 RUMINANTS: DIRECT-FED MICROBIALS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION)
Table 15 AQUATIC ANIMALS: DIRECT-FED MICROBIALS MARKET SIZE, BY REGION, 2014–2022(USD MILLION)
Table 16 OTHERS: DIRECT-FED MICROBIALS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION)
Table 17 DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2014–2022 (USD MILLION)
Table 18 DRY DIRECT-FED MICROBIALS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION)
Table 19 LIQUID DIRECT-FED MICROBIALS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION)
Table 20 DIRECT-FED MICROBIALS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION)
Table 21 NORTH AMERICA: DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY, 2014–2022 (USD MILLION)
Table 22 NORTH AMERICA: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 23 NORTH AMERICA: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 24 NORTH AMERICA: DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2014–2022 (USD MILLION)
Table 25 U.S.: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 26 U.S.: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 27 CANADA: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 28 CANADA: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 29 MEXICO: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 30 MEXICO: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 31 EUROPE: DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY, 2014–2022 (USD MILLION)
Table 32 EUROPE: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 33 EUROPE: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 34 EUROPE: DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2014–2022 (USD MILLION)
Table 35 U.K.: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 36 U.K.: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 37 GERMANY: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 38 GERMANY: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 39 FRANCE: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 40 FRANCE: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 41 ITALY: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 42 ITALY: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 43 SPAIN: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 44 SPAIN: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 45 REST OF EUROPE: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 46 REST OF EUROPE: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 47 ASIA-PACIFIC: DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY, 2014–2022 (USD MILLION)
Table 48 ASIA-PACIFIC: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 49 ASIA-PACIFIC: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 50 ASIA-PACIFIC: DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2014–2022 (USD MILLION)
Table 51 CHINA: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 52 CHINA: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 53 INDIA: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 54 INDIA: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 55 JAPAN: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 56 JAPAN: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 57 REST OF ASIA-PACIFIC: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 58 REST OF ASIA-PACIFIC: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 59 ROW: DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY, 2014–2022 (USD MILLION)
Table 60 ROW: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 61 ROW: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 62 ROW: DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2014–2022 (USD MILLION)
Table 63 LATIN AMERICA: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 64 LATIN AMERICA: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 65 MEA: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION)
Table 66 MEA: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION)
Table 67 EXPANSIONS & INVESTMENTS, 2011–2016
Table 68 MERGERS & ACQUISITIONS, 2011–2016
Table 69 NEW PRODUCT LAUNCHES, 2011–2016
Table 70 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES, 2011–2016
Table 71 EXPANSIONS & INVESTMENTS, 2011–2016
Table 72 MERGERS & ACQUISITIONS, 2011–2016

LIST OF FIGURES

Figure 1 DIRECT-FED MICROBIALS MARKET SEGMENTATION
Figure 2 RESEARCH DESIGN
Figure 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
Figure 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
Figure 5 DATA TRIANGULATION
Figure 6 DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2016 VS. 2022 (USD MILLION)
Figure 7 LACTIC ACID BACTERIA PROJECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE DIRECT-FED MICROBIALS MARKET FROM 2016 TO 2022
Figure 8 DRY FORM IS PROJECTED TO DOMINATE THE DIRECT-FED MICROBIALS MARKET THROUGH 2022
Figure 9 NORTH AMERICA ACCOUNTED FOR THE LARGEST MARKET SHARE FOR DIRECT-FED MICROBIALS IN 2015
Figure 10 DIRECT-FED MICROBIALS MARKET: AN EMERGING MARKET WITH PROMISING GROWTH POTENTIAL, 2016-2022
Figure 11 POULTRY ACCOUNTED FOR THE LARGEST SHARE IN THE DIRECT-FED MICROBIALS MARKET, 2016-2022
Figure 12 DIRECT-FED MICROBIALS MARKET IN NORTH AMERICA IS EXPERIENCING HIGH GROWTH
Figure 13 LACTIC ACID BACTERIA IS EXPECTED TO DOMINATE THE MARKET THROUGHOUT THE FORECAST PERIOD
Figure 14 GERMANY IS PROJECTED TO BE FASTEST-GROWING MARKET, 2016-2022
Figure 15 EUROPE ACCOUNTED FOR THE LARGEST SHARE IN THE FORM SEGMENT OF THE DIRECT-FED MICROBIALS MARKET IN 2015
Figure 16 GLOBAL RUMINANTS POPULATION, 2000-2015, BILLION HEADS
Figure 17 DIRECT-FED MICROBIALS MARKET, BY TYPE
Figure 18 DIRECT-FED MICROBIALS MARKET, BY FORM
Figure 19 DIRECT-FED MICROBIALS MARKET, BY LIVESTOCK
Figure 20 DIRECT-FED MICROBIALS MARKET, BY REGION
Figure 21 MARKET DYNAMICS SNAPSHOT
Figure 22 STRAIN DEVELOPMENT AND MARKETING AND SALES PLAY A VITAL ROLE IN THE SUPPLY CHAIN OF DIRECT-FED MICROBIALS IN ANIMAL FEED
Figure 23 DIRECT-FED MICROBIALS MARKET: PORTER’S FIVE FORCES ANALYSIS
Figure 24 LACTIC ACID BACTERIA SEGMENT TO BE THE FASTEST-GROWING BY 2022
Figure 25 DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2016-2022
Figure 26 DRY SEGMENT TO DOMINATE THE DIRECT-FED MICROBIALS MARKET THROUGH 2022
Figure 27 U.S. ACCOUNTED FOR THE LARGEST SHARE IN THE NORTH AMERICAN DIRECT-FED MICROBIALS MARKET
Figure 28 EUROPE: DIRECT-FED MICROBIALS MARKET SNAPSHOT
Figure 29 GLOBAL DIRECT-FED MICROBIALS COMPANY RANKINGS (2015)
Figure 30 BATTLE FOR MARKET SHARE: EXPANSIONS AND INVESTMENTS WAS THE MOST POPULAR GROWTH STRATEGY
Figure 31 EXPANSIONS & INVESTMENTS FUELED GROWTH AND INNOVATION (2014–2016)
Figure 32 ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT
Figure 33 ARCHER DANIELS MIDLAND COMPANY: SWOT ANALYSIS
Figure 34 E.I. DUPONT DE NEMOURS AND COMPANY: COMPANY SNAPSHOT
Figure 35 E. I. DU PONT DE NEMOURS AND COMPANY: SWOT ANALYSIS
Figure 36 KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT
Figure 37 KONINKLIJKE DSM N. V.: SWOT ANALYSIS
Figure 38 NOVOZYMES: COMPANY SNAPSHOT
Figure 39 NOVOZYMES: SWOT ANALYSIS
Figure 40 CHR. HANSEN A/S: COMPANY SNAPSHOT
Figure 41 CHR. HANSEN A/S: SWOT ANALYSIS


More Publications